Publication | Open Access

Synthesis and biological evaluation of moxifloxacin-acetyl-1,2,3-1H-triazole-methylene-isatin hybrids as potential anti-tubercular agents against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains

Pulmonary TuberculosisPotential Anti-tubercular AgentsAntibioticsMedicineTuberculosisMoxifloxacin-acetyl-1,2,3-1h-triazole-methylene-isatin HybridsBiological EvaluationAntibacterial AgentMicrobiologyAntimicrobial CompoundPharmacologyAntimicrobial ResistanceDrug DiscoveryDrug Resistance